摘要
本文主要通过收集景德镇市2012-2018年参麦注射液ADR/ADE报告中对ADR评价为肯定、很可能和可能的共261例,对患者的人群特征、给药途径、用法用量、ADR/ADE临床表现,探讨参麦注射液不良反应的表现、类型、不良反应的发生率及其影响因素,以期为本地区临床安全使用参麦注射剂提供参考。
The analysis of Shenmai injection ADR epidemiology were based on 261 cases of ADR reports downloaded by National ADR Monitoring from 2012 to 2018.The analysis was conducted on the patients′gender,age,administration route,usage and dosage,and clinical manifestations.By investigating the characteristics of ADR caused by Shenmai injection,we detect the incidence and influencing factors of adverse reactions in order to provid further references for rational Shenmai injection in the region.
引文
[1]石庆平,姜晓东,桑冉,等.参麦注射液不良反应影响因素Logistic回归分析[J].中国医院药学杂志,2013,33(7):587-589.
[2]王连心,谢雁鸣,艾青华,et al.参麦注射液上市后再评价系列研究[J].世界中医药,2014(9).
[3]王燕俊,陈婷,王建平,等.静脉药物配置环境下13种中药注射剂配置后不溶性微粒的测定[J].中华中医药学刊,2012(12):2663-2666.
[4]尹梅,程平.输液与中药注射液配伍微粒变化考察[J].中成药,2000,22(4).
[5]王丽,尹桃,朱敏文.参麦注射液不良反应回顾性研究[J].中南药学,2007,5(3):273-276.
[6]丁峰,石庆平,姜晓东,et al.Logistic模型和ROC曲线对参麦注射液致不良反应的预测分析[J].中国中药杂志,2015,40(7):1404.
[7]赵全凤.重庆市药品不良反应流行病学特点研究[D].重庆:重庆医科大学,2016:40.